CE marking for medical devices is achieved by correctly classifying your device under EU MDR 2017/745, building a compliant quality management system, compiling technical documentation with clinical and risk evidence, completing the applicable conformity assessment route, signing an EU Declaration of Conformity, and registering in EUDAMED before affixing the mark. There is no single universal “CE certificate” — the process, cost, and timeline depend entirely on your device’s classification.
A practitioner’s walk-through of CE marking under EU MDR 2017/745 — classification, documentation, conformity assessment, cost drivers, and the mistakes that most often delay approval.
What Is CE Marking for Medical Devices?
CE marking (Conformité Européenne) is a regulatory mark, not a quality award. Affixing it to a medical device is a manufacturer’s legal declaration — backed by documented evidence — that the device meets the essential safety and performance requirements set out in EU MDR 2017/745 (or, for in vitro diagnostics, EU IVDR 2017/746).
A few distinctions matter here, because “CE certification” is often used loosely in a way that misleads manufacturers:
- CE marking is not a single certificate. For lower-risk devices, it is a self-declared conformity, not a certificate issued by an external body at all.
- There is no single “CE certification body.” For devices that do require external assessment, an independent, EU-designated Notified Body carries it out — not a government office, and not one universal international agency.
- The manufacturer affixes the mark, not the Notified Body. A Notified Body certifies your quality management system and/or technical documentation; you remain legally responsible for the declaration.
Is CE Marking Mandatory for Medical Devices?
Yes. Under EU MDR, no medical device — regardless of where it is manufactured — may be legally placed on the EU market, put into service, or made available to EU customers without a valid CE mark, unless it qualifies for a specific exemption such as custom-made or investigational devices. This applies equally to a company based in the EU, India, the US, or elsewhere.
Which devices fall under EU MDR?
EU MDR defines a medical device broadly: any instrument, apparatus, appliance, software, implant, reagent, material, or other article intended for a medical purpose — diagnosis, prevention, monitoring, treatment, or alleviation of disease, injury, or disability. This includes standalone software meeting the medical-purpose definition (SaMD), implantable and surgically invasive devices, non-invasive devices such as wound dressings and diagnostic equipment, and accessories intended specifically for use with a medical device. Most in vitro diagnostics fall under the related EU IVDR rather than EU MDR itself.
Medical Device Classification: Why It Decides Everything
Classification is the single most important early decision in the CE marking process — it determines your conformity assessment route, documentation depth, whether a Notified Body is involved, and realistically, your cost and timeline. EU MDR Annex VIII sets out 22 risk-based classification rules, considering duration of body contact, invasiveness, whether the device is active or passive, and whether it administers or removes a substance from the body.
| Class | Risk | Typical examples | Assessment route |
|---|---|---|---|
| Class I | Low | Non-sterile bandages, wheelchairs, exam gloves | Self-declaration by manufacturer |
| Class I s/m/r | Low–Med | Sterile dressings, reusable surgical instruments | Notified Body, limited scope |
| Class IIa | Medium | Hearing aids, ultrasound equipment, dental fillings | Notified Body — QMS + tech file |
| Class IIb | Med–High | Infusion pumps, ventilators, long-term lenses | Notified Body — deeper file review |
| Class III | High | Pacemakers, spinal implants, heart valves | Full assessment + clinical investigation |
Core CE Marking Requirements for Medical Devices
Whatever your device class, EU MDR builds every requirement around a few pillars: General Safety and Performance Requirements (Annex I), risk management aligned with ISO 14971, clinical evaluation, structured technical documentation, a quality management system, UDI and EUDAMED registration, and ongoing post-market surveillance and vigilance.
Harmonised standards give you a shortcut
Where a device conforms to a harmonised standard published in the EU Official Journal, manufacturers get a “presumption of conformity” with the corresponding MDR requirement. Commonly relevant standards: ISO 13485 (quality management), ISO 14971 (risk management), IEC 62304 (medical device software), EN ISO 10993 series (biological evaluation), and EN 60601-1 (electrical safety). Standards are periodically revised — always confirm the current harmonised version before finalising your technical file.
Is ISO 13485 mandatory?
Not universally by law for every class, but in practice it is close to unavoidable. Any device requiring Notified Body involvement effectively needs a quality management system satisfying MDR Article 10(9), and Notified Bodies overwhelmingly expect this structured around ISO 13485:2016. Even Class I self-declaring manufacturers benefit, since it organises design controls, document management, and CAPA processes that MDR technical documentation depends on.
Read Also: CE Marking for Medical Devices
The CE Marking Process for Medical Devices: Step by Step
The practical sequence a manufacturer can actually follow — though some steps run in parallel rather than strictly one after another.
Confirm intended purpose and classify the device
Write a precise intended-purpose statement, then apply the Annex VIII rules. This single decision shapes every step that follows.
Identify applicable harmonised standards
Map your GSPRs (Annex I) against the standards and evidence you will need to demonstrate compliance.
Establish or upgrade your QMS
Build design controls, document control, supplier management, complaint handling, and internal audit processes, generally aligned with ISO 13485.
Conduct risk management
Identify hazards, estimate and evaluate risks, implement controls, and document residual risk acceptability per ISO 14971.
Carry out clinical evaluation
Gather clinical data from investigations, equivalent-device literature, or PMCF, and compile a Clinical Evaluation Report. The evidentiary bar is meaningfully higher than under MDD, especially for Class IIb/III.
Compile technical documentation
Assemble device description, design/manufacturing information, GSPR checklist with evidence, risk file, clinical evaluation, labelling, and IFU.
Appoint an EU Authorised Representative
Mandatory for non-EU manufacturers. Your EU AR is registered in EUDAMED and carries specific legal obligations alongside you.
Engage a Notified Body, where required
Select a body designated for your device category in the NANDO database, submit documentation, and undergo QMS audit and file review.
Register in EUDAMED
Register as an economic operator, register the device with its UDI, and submit required data modules as they become mandatory.
Sign the EU Declaration of Conformity
The manufacturer's own legal statement that the device meets all applicable MDR requirements — not the Notified Body's.
Affix the CE mark and place on the market
Apply the mark — and where applicable, the Notified Body's four-digit ID number — to the device, packaging, and documentation.
Maintain post-market surveillance
Run PMS activities, submit Periodic Safety Update Reports where required, report serious incidents within applicable timeframes, and keep the technical file current.
CE Marking Documents for Medical Devices
The exact documentation set is not universal — it scales with device class and conformity assessment route. Most manufacturers prepare some combination of:
- Technical documentation (Annex II/III) — device description, design and manufacturing details, GSPR checklist
- Risk management documentation — hazard analysis, risk controls, residual risk evaluation
- Clinical evaluation documentation — CER, literature search protocol and results, or clinical investigation data
- QMS records — procedures, design history, internal audits, CAPA records
- Labelling and Instructions for Use — in the official languages of every EU member state targeted
- Test reports — biocompatibility, electrical safety, software V&V, as applicable
- EU Declaration of Conformity and, where relevant, the Notified Body certificate
- Summary of Safety and Clinical Performance (SSCP) — implantable and Class III devices, published via EUDAMED
A Class I bandage manufacturer and a Class III implant manufacturer work from the same regulation, but the depth and volume of these documents differ enormously — treat any “universal checklist” with caution and confirm your specific scope against your classification.
CE Marking Cost for Medical Devices: What Actually Drives It
There is no fixed EU government fee for CE marking, and any guide quoting one flat number is oversimplifying. Cost is driven by a combination of variables worth understanding individually rather than anchoring on a single figure.
| Cost driver | Why it matters |
|---|---|
| Device classification | Determines whether Notified Body fees apply at all, and review depth |
| Product complexity | More components, software, or novel technology → more testing and documentation |
| Testing & biocompatibility | Electrical safety, software V&V, and biological evaluation scale with risk |
| Clinical evaluation depth | A literature-based CER costs far less than a dedicated clinical investigation |
| Technical documentation effort | Internal staff time or consultant support to build a defensible, traceable file |
| QMS implementation | Building ISO 13485 from scratch costs more than upgrading an existing system |
| Notified Body fees | Vary by body, device category, and review scope — get direct quotes |
| Post-market obligations | PMS, PMCF, and vigilance are recurring, not one-time costs |
How Long Does CE Marking Take?
Timelines follow the same logic as cost: they scale with classification and readiness. Class I self-declared devices can move markedly faster than devices requiring Notified Body review, and Class III devices with clinical investigation requirements take considerably longer than any other category. Beyond your own documentation readiness, Notified Body capacity is a major variable — the MDD-to-MDR transition left many designated bodies with significant application backlogs, so early engagement matters more than most manufacturers expect. No consultant or regulatory body can guarantee a fixed timeline or approval outcome.
Legacy devices: a related but separate question
If you already hold an MDD certificate and are transitioning an existing device rather than launching a new one, note that the EU has staggered extended transition deadlines for legacy devices under Regulation (EU) 2023/607 — running through 2027 and 2028 depending on device class, subject to conditions such as a written agreement with an MDR-designated Notified Body. This is distinct from a first-time CE marking application; confirm current dates against MDCG guidance and your Notified Body.
Common Mistakes Manufacturers Make
- ✕ Misclassifying the device by carrying over an old MDD classification instead of reapplying the Annex VIII rules
- ✕ Underestimating clinical evidence — assuming a literature review will suffice for higher-risk devices
- ✕ Generic, templated risk files that don’t reflect the actual device and its specific hazards
- ✕ Incomplete technical documentation, particularly a GSPR checklist with vague references instead of traceable evidence
- ✕ Leaving Notified Body engagement too late, given ongoing capacity constraints across the EU
- ✕ Treating CE marking as a one-time project rather than an ongoing commitment involving PMS, PMCF, and vigilance
- ✕ Inconsistent labelling and IFU across the EU languages actually required for target markets
- ✕ Misunderstanding the Notified Body’s role, assuming their certificate replaces the manufacturer’s own legal responsibility
Working With a CE Marking Consultant for Medical Devices
A CE marking consultant does not replace the manufacturer’s legal responsibility, but experienced regulatory support can meaningfully reduce rework and delay by helping with device classification review, ISO 13485 gap analysis and implementation, structuring technical documentation and the GSPR checklist, risk management documentation, clinical evaluation strategy, EU Authorised Representative coordination, Notified Body audit readiness, EUDAMED/UDI registration, and post-market surveillance design.
No consultant can guarantee approval, a fixed timeline, or Notified Body outcomes — anyone who does is overpromising. What good regulatory support can do is reduce avoidable errors and keep your submission on a realistic, defensible track.
Why Choose TraccGlobal?
TraccGlobal is a regulatory consultancy supporting medical device manufacturers, including Indian manufacturers, on global market access — with dedicated experience across CE marking under EU MDR and ISO 13485 quality management system implementation. Its team works with manufacturers on classification, technical documentation, and regulatory strategy rather than handing over generic templates, and supports related documentation work such as Design History Files that feed directly into a CE marking technical file. If you’re weighing your CE pathway alongside other markets, the team can also walk you through how it fits with UKCA marking or MDSAP for manufacturers targeting multiple regions.
Frequently Asked Questions
Is CE marking mandatory for medical devices sold in the EU?
How much does CE marking cost for a medical device?
How long does the CE marking process take?
Is a Notified Body required for every medical device?
What documents are needed for CE marking?
Is ISO 13485 mandatory for CE marking?
Is a CE marking consultant necessary?
Company credentials
ISO 9001, ISO 27001 & ISO 45001 certified consultancy
Contact
info@traccglobal.com
